PharmaCyte Biotech | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)等
02/14 15:45 (美东)
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%)等
02/06 10:01 (美东)
PharmaCyte Biotech | 3:首次持股声明-股东 PharmaCyte Biotech, Inc.
2023/11/28 17:06 (美东)
PharmaCyte Biotech | 4:持股变动声明-董事 WEINSTEIN ROBERT
2023/11/22 17:02 (美东)
PharmaCyte Biotech | 4:持股变动声明-董事 WALKER WAYNE REMELL
2023/11/22 17:02 (美东)
PharmaCyte Biotech | 4:持股变动声明-首席财务官 Trujillo Carlos
2023/11/22 17:01 (美东)
PharmaCyte Biotech | 4:持股变动声明-高管 Silverman Joshua
2023/11/22 17:01 (美东)
PharmaCyte Biotech | 4:持股变动声明-董事 SCHECHTER JONATHAN
2023/11/22 17:01 (美东)
PharmaCyte Biotech | 4:持股变动声明-董事 Abecassis Michael M
2023/11/22 17:00 (美东)
PharmaCyte Biotech | SC 13D:超过5%持股股东披露文件-PharmaCyte Biotech, Inc.(37.0%)
2023/11/22 16:00 (美东)
PharmaCyte Biotech | SC 13D/A:超过5%持股股东披露文件(修正)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%)等
2023/06/16 17:22 (美东)
PharmaCyte Biotech | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%)等
2023/05/19 17:19 (美东)
PharmaCyte Biotech | SC 13D/A:超过5%持股股东披露文件(修正)-Richard Abbe(7.0%),Iroquois Master Fund Ltd.(6.6%)等
2023/05/12 16:22 (美东)
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-Shay Capital LLC(0.00%),Shay Capital Holdings LLC(0.00%)
2023/02/14 16:30 (美东)
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-Daniel B. Asher(9.99%),Mitchell P. Kopin(8.4%)等
2023/02/08 06:05 (美东)
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)
2023/01/10 11:57 (美东)
PharmaCyte Biotech | 3:首次持股声明-董事 WALKER WAYNE REMELL
2022/12/30 16:06 (美东)
PharmaCyte Biotech | 4:持股变动声明
2022/12/30 16:05 (美东)
PharmaCyte Biotech | 4:持股变动声明
2022/12/30 16:05 (美东)
PharmaCyte Biotech | 3:首次持股声明-董事 WEINSTEIN ROBERT
2022/11/16 16:12 (美东)
暂无数据
暂无数据